Gender differences in diazepam withdrawal syndrome in mice

Area of Science:

• Neuroscience
• Endocrinology
• Pharmacology

Background:

• Benzodiazepine dependence and withdrawal are significant clinical concerns.
• Sex differences in drug response and withdrawal are increasingly recognized.
• The role of sex hormones in modulating neurotransmitter systems is not fully understood.

Purpose of the Study:

• To investigate the influence of testosterone and estrogens on benzodiazepine withdrawal syndrome in mice.
• To determine if sex hormones affect the severity and specific signs of withdrawal.
• To explore the potential role of testosterone in mitigating benzodiazepine withdrawal.

Main Methods:

• Diazepam was administered to mice to induce dependence.
• Benzodiazepine withdrawal was precipitated using flumazenil.
• Withdrawal signs, including seizures, were quantified in male and female mice.
• Castration was performed on male mice to assess the role of testosterone.

Main Results:

• Male mice exhibited a significantly less intense benzodiazepine withdrawal syndrome than female mice, particularly regarding seizure incidence.
• Castration of male mice led to a significant increase in withdrawal syndrome intensity.
• Diazepam administration caused a significant increase in body weight in males but not females.

Conclusions:

• Testosterone plays a significant role in modulating the intensity of benzodiazepine withdrawal syndrome.
• Sexual hormones, especially testosterone, influence the mechanism of action of benzodiazepines.
• Findings suggest potential therapeutic targets for managing benzodiazepine withdrawal by considering sex hormone levels.